Calculate exact injection volumes, concentrations, and doses per vial for Tirzepatide protocols.
⚠️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any peptide or medication protocol.
⚡ Tirzepatide Dose Calculator
Concentration—
Volume Per Injection—
Insulin Syringe Units—
Doses Per Vial—
📱 Track Every Dose with DoseIQ
The #1 peptide tracking app for iPhone. Calculate doses, log injections, set reminders, and track your progress.
Tirzepatide (Mounjaro/Zepbound) is the first dual GIP/GLP-1 receptor agonist, producing superior weight loss vs semaglutide — averaging 20–22% body weight reduction in the SURMOUNT trials. By activating both GIP and GLP-1 receptors, it enhances insulin sensitivity, reduces appetite via dual hypothalamic pathways, slows gastric emptying, and improves beta-cell function. FDA-approved for type 2 diabetes (Mounjaro) and weight management (Zepbound). Starting dose: 2.5 mg weekly, titrated every 4 weeks to 15 mg maximum. Track your tirzepatide titration schedule with the DoseIQ app.